HLB Therapeutics Co.,Ltd.
115450
Rank in Stocks
#18706
HLB Therapeutics Co.,Ltd. operates as a biotechnology company, focusing on the... HLB Therapeutics Co.,Ltd. operates as a biotechnology company, focusing on the creation of pharmaceutical products for both the South Korean and international markets. A significant part of its research and development initiatives includes GBT-201, a compound utilizing Thymosin beta designed to treat various eye ailments such as dry eye syndrome and neurotrophic keratopathy. Additionally, the company is advancing OKN-007 as a potential therapy for glioblastoma brain tumors. Beyond its pharmaceutical endeavors, HLB Therapeutics is also involved in the wholesale distribution of vaccines and the production of electrical and electronic components like motors, pumps, and transformers. The company, which established its roots in 2000 and is based in Seongnam, South Korea, underwent a name change in December 2021, transitioning from its former identity as G-treeBNT Co., Ltd. to its current designation.
Share Price
$1.87
Market Cap
$176.60M
Change (1 day)
-0.37%
Change (1 year)
-10.63%
Country
KR
Trade HLB Therapeutics Co.,Ltd. (115450)
Category
Healthcare
Stock split history for HLB Therapeutics Co.,Ltd. (115450)
HLB Therapeutics Co.,Ltd. stock (symbol: 115450) underwent a total of 0 stock splits.
The most recent stock split occurred on Oct 21, 2026.
One 115450 share bought prior to Oct 21, 2026 would equal to 0 115450 shares today.
The most recent stock split occurred on Oct 21, 2026.
One 115450 share bought prior to Oct 21, 2026 would equal to 0 115450 shares today.
Stock split list
| Year | Split | Multiple | Cumulative Multiple |
|---|---|---|---|
| Not enough data for the provided dates. | |||
Stock splits for similar companies or competitors
| Company | Number of stock splits | Cumulative Multiple | Country |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
NL
|
|
| 0 | - |
CH
|
